市場調査レポート
商品コード
1443444

マウスモデルの世界市場:モデルタイプ、サービス、技術、治療領域、用途別 - 予測(~2029年)

Mice Model Market by Model Types, Services, Technology, Therapeutic Area, Application - Global Forecast to 2029

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 369 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
マウスモデルの世界市場:モデルタイプ、サービス、技術、治療領域、用途別 - 予測(~2029年)
出版日: 2024年02月27日
発行: MarketsandMarkets
ページ情報: 英文 369 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のマウスモデルの市場規模は、2024年の15億米ドルから、予測期間中に8.1%のCAGRで推移し、2029年には22億米ドルの規模に成長すると予測されています。

同市場の成長は、新しい薬剤の発見や開発を目的とした研究開発努力、研究におけるマウスモデルの活用、腫瘍分野の個別化治療への注目の高まりに起因すると考えられています。

調査範囲
調査対象年 2022-2029年
基準年 2023年
予測期間 2024-2029年
単位 金額 (米ドル)
セグメント モデルタイプ&サービス・技術・治療領域・用途・エンドユーザー別
対象地域 北米・欧州・アジア太平洋・ラテンアメリカ・中東&アフリカ

モデルタイプ&サービス別では、モデルタイプの部門が2023年に最大のシェアを示しました。マウスの遺伝子がヒトと類似していること、またマウスモデルはヒトの疾患の研究、新薬や治療法の試験、生物学的プロセスの理解において重要な役割を果たしていることなどの要因が同部門の成長を促進しています。

地域別では、アジア太平洋地域が予測期間中にもっとも高いCAGRで成長する見通しです。マウスモデルを用いた前臨床試験の採用の拡大やヘルスケア分野の活況など、さまざまな要因が同地域のマウスモデル市場の成長を後押ししています。

新規技術を開発するための製薬企業やバイオ技術企業からの資金調達や投資の増加が、アジア太平洋地域におけるマウスモデル市場の成長を促進すると期待されています。同地域ではバイオ医療研究や医薬品開発への投資が続いているため、前臨床研究や創薬活動をサポートするマウスモデルの需要が高まっています。さらに、アジア太平洋諸国における慢性疾患の有病率の増加が、疾患のメカニズムをよりよく理解し、潜在的な治療法を試験するための信頼性の高い動物モデルの必要性を促進しています。

当レポートでは、世界のマウスモデルの市場を調査し、市場概要、市場影響因子および市場機会の分析、特許の動向、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • マウスモデル市場情勢
  • サプライチェーン分析
  • バリューチェーン分析
  • 価格分析
  • エコシステム分析
  • 顧客のビジネスに影響を与える動向/ディスラプション
  • 特許分析
  • 主な会議とイベント
  • 規制状況
  • ポーターのファイブフォース分析
  • 主なステークホルダーと購入基準

第6章 マウスモデル市場:モデルタイプ・サービス別

  • モデルタイプ
    • 近交系マウス
    • 遺伝子操作マウス
    • ハイブリッド/コンジェニックマウス
    • 非近交系マウス
  • サービス
    • 繁殖サービス
    • 冷凍保存サービス
    • 再利用サービス
    • 検疫サービス
    • その他のサービス

第7章 マウスモデル市場:技術別

  • CRISPR/CAS9
  • マイクロインジェクション
  • ES細胞注射
  • 核移転
  • その他

第8章 マウスモデル市場:治療領域別

  • 腫瘍
  • 代謝性疾患
  • 免疫
  • 神経
  • 心血管疾患
  • その他

第9章 マウスモデル市場:用途別

  • 創薬・開発
  • 研究
  • 個別化医療

第10章 マウスモデル市場:エンドユーザー別

  • 製薬およびバイオ技術会社
  • 学術&研究機関
  • CRO・CDMO

第11章 マウスモデル市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第12章 競合情勢

  • 概要
  • 主要企業の戦略/有力企業
  • 収益シェア分析
  • 市場シェア分析
  • 財務指標
  • ブランド/製品の比較分析
  • 企業評価マトリックス:主要企業
  • 企業評価マトリックス:スタートアップ/中小企業
  • 競合シナリオ

第13章 企業プロファイル

  • 主要企業
    • CHARLES RIVER LABORATORIES
    • INOTIV
    • THE JACKSON LABORATORY
    • SHANGHAI MODEL ORGANISMS CENTER, INC.
    • JSR CORPORATION
    • BIOCYTOGEN
    • TRANS GENIC INC.
    • HARBOUR BIOMED
    • GENOWAY
    • GEMPHARMATECH
    • CYAGEN
    • OZGENE PTY LTD.
    • TACONIC BIOSCIENCES, INC.
    • TRANSCURE BIOSERVICES
    • MARSHALL BIORESOURCES
    • VIVO BIO TECH LTD.
    • INGENIOUS TARGETING LABORATORY
    • JANVIER LABS
  • その他の企業
    • APPLIED STEMCELL
    • CREATIVE ANIMODEL
    • JOINN LABORATORIES (CHINA) CO., LTD.
    • CREATIVE BIOLABS
    • CRESCENDO BIOLOGICS
    • ARAGEN LIFE SCIENCES
    • POLYGENE

第14章 付録

目次
Product Code: BT 2192

The mice model market is projected to reach USD 2.2 billion by 2029 from an estimated USD 1.5 billion in 2024, at a CAGR of 8.1% during the forecast period. The growth of this market can be attributed to the research and development efforts aimed at drug discovery and development for novel therapies and employment of mice model in studies, and the growing focus on personalized medicines in oncology.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsModel Type & Service, Technology, Therapeutic Area, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"The model type segment accounted for the largest share by model type & service in 2023."

In 2023, the model type segment accounted for the largest share of model type & service segment in the global mice model market. The factors such as the genetic similarity of mice with that of humans, also the mice models play a crucial role in studying human diseases, testing new drugs and therapies, and understanding biological processes are driving the growth of this market.

"The Asia Pacific region is growing at the highest CAGR in the mice model market during the forecast period of 2024-2029."

The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. Various factors including growing adoption of mice model based pre-clinical studies and booming healthcare sector are propelling the growth of mice model market in the region.

Increased funding and investments from pharmaceutical and biotechnology companies to develop novel technologies are expected to propel the growth of the mice model market in the Asia Pacific region. As the region continues to invest in biomedical research and pharmaceutical development, there is a growing demand for mice models to support preclinical studies and drug discovery efforts. Additionally, the increasing prevalence of chronic diseases in Asia-Pacific countries has fueled the need for reliable animal models to better understand disease mechanisms and test potential therapies.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: C-level Executives - 55%, Director-level - 20%, and Others - 25%
  • By Region: North America -45%, Europe -20%, Asia-Pacific -20%, Latin America -10%, Middle East-3%, and Africa- 2%

List of Companies Profiled in the Report:

  • Charles River Laboratories (US)
  • Inotiv (US)
  • THE JACKSON LABORATORY (US)
  • GemPharmatech (China)
  • Cyanogen (US)
  • Shanghai Model Organisms Center, Inc. (China)
  • JSR Corporation (Japan)
  • Biocytogen (China)
  • TRANS GENIC INC. (Japan)
  • Ozgene Pty Ltd. (Australia)
  • Taconic Biosciences, Inc. (US)
  • TransCure bioServices (France)
  • Harbour BioMed (China)
  • Marshall BioResources (US)
  • genOway (France)
  • Vivo Bio Tech Ltd. (India)
  • ingenious targeting laboratory (US)
  • Janvier Labs (France)
  • Applied StemCell (US)
  • Creative Animodel (US)
  • JOINN Laboratories Co., Ltd. (China)
  • Creative Biolabs (US)
  • Crescendo Biologics (UK)
  • Aragen Life Sciences (India)
  • PolyGene (Switzerland)

Research Coverage:

This research report categorizes the mice model market market by model type & service (model type & service), technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), therapeutic area (oncology, neurology, metabolic diseases, immunology, cardiovascular diseases, and other diseases), application (drug discovery & development, research application, and personalized medicine) end user (pharmaceutical & biotechnology companies, academic & research institutes, and CROs and CDMOs), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report provides in-depth information on significant factors influencing the growth of the mice model market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products/services, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches, mergers, and acquisitions within the mice model market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mice model market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Genetic & physiological versatility of mice models in preclinical studies, increasing demand for mouse clinical trials (MCTs), rising demand for personalized medicine in oncology, genetic engineering advancement), restraints (Introduction of 3D, ethical concerns and regulatory restrictions), opportunities (Utilization of CRISPR in biomedical research, rising demand for disease-specific models), and challenges (Development of alternative animal testing methods, genetic and phenotypic variability) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products/services of the mice model market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the mice model market
  • Competitive Assessment: Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), GemPharmatech (China), Cyagen (US), Shanghai Model Organisms Center, Inc. (China), JSR Corporation (Japan), Biocytogen (China), TRANS GENIC INC. (Japan), Ozgene Pty Ltd. (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Harbour BioMed (China), Marshall BioResources (US), genOway (France), Vivo Bio Tech Ltd. (India), ingenious targeting laboratory (US), Janvier Labs (France), Applied StemCell (US), Creative Animodel (US), JOINN Laboratories Co., Ltd. (China), Creative Biolabs (US), Crescendo Biologics (UK), Aragen Life Sciences (India), and PolyGene (Switzerland), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS
  • 1.8 SUMMARY OF CHANGES
  • 1.9 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MICE MODEL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES: REVENUE SHARE ANALYSIS (2023)
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 TOP-DOWN APPROACH
    • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.4 GROWTH FORECAST
    • FIGURE 8 MICE MODEL MARKET: CAGR PROJECTIONS
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 MARKET FORECAST
    • TABLE 1 FACTOR ANALYSIS
  • 2.8 RISK ANALYSIS
  • 2.9 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 MICE MODEL MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 MICE MODEL MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICE MODEL MARKET

4 PREMIUM INSIGHTS

  • 4.1 MICE MODEL MARKET OVERVIEW
    • FIGURE 15 RISING INVESTMENTS AND ADVANCEMENTS IN MOUSE MODEL TECHNOLOGY TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE (2023)
    • FIGURE 16 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.3 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 MICE MODEL MARKET SHARE, BY END USER
    • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 MICE MODEL MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High adoption of mice models in preclinical studies
      • 5.2.1.2 Increasing demand for mouse clinical trials (MCTs)
      • 5.2.1.3 Growing preference for personalized medicine in oncology
      • 5.2.1.4 Advancements in genetic engineering
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Introduction of 3D printed models
      • 5.2.2.2 Ethical concerns and regulatory restrictions
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Utilization of CRISPR in biomedical research
      • 5.2.3.2 Rising demand for disease-specific models
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Development of alternative animal testing methods
      • 5.2.4.2 Genetic & Phenotypic variability
  • 5.3 MICE MODEL MARKET LANDSCAPE
    • 5.3.1 HISTORY OF MICE MODELS
    • 5.3.2 MICE MODEL GENERATION PROCESS
    • 5.3.3 TECHNIQUES FOR MICE MODEL DEVELOPMENT
    • 5.3.4 TECHNOLOGICAL ADVANCEMENTS
    • 5.3.5 CONSIDERATIONS FOR MICE MODEL DEVELOPMENT
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 21 MICE MODEL MARKET: VALUE CHAIN ANALYSIS
  • 5.6 PRICING ANALYSIS
    • TABLE 3 AVERAGE SELLING PRICE TREND OF MODEL TYPE, BY KEY PLAYER
    • 5.6.1 AVERAGE SELLING PRICE TREND ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 22 MICE MODEL MARKET: ECOSYSTEM ANALYSIS
    • 5.7.1 MICE MODEL VENDORS
    • TABLE 4 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY MICE MODEL VENDORS
    • 5.7.2 MICE MODEL SERVICE VENDORS
    • TABLE 5 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR
    • 5.7.3 MICE MODEL END USERS
    • TABLE 6 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY END USER
    • 5.7.4 REGULATORY ORGANIZATIONS
    • TABLE 7 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 PATENT ANALYSIS
    • 5.9.1 METHODOLOGY
    • 5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
    • TABLE 8 PATENTS FILED (2014-2024)
    • 5.9.3 INNOVATION & PATENT APPLICATIONS
    • FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED (2014-2024)
    • 5.9.4 TOP APPLICANTS
    • FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS (2014-2024)
    • TABLE 9 TOP 20 PATENT OWNERS IN MICE MODEL MARKET (2014-2024)
    • TABLE 10 PATENTS IN MICE MODEL MARKET (2024)
  • 5.10 KEY CONFERENCES & EVENTS
    • 5.10.1 MICE MODEL MARKET: KEY CONFERENCES & EVENTS (2024-2025)
    • TABLE 11 MICE MODEL MARKET: CONFERENCES & EVENTS (2024-2025)
  • 5.11 REGULATORY LANDSCAPE
    • 5.11.1 REGULATORY ANALYSIS
      • 5.11.1.1 North America
      • 5.11.1.2 Europe
      • 5.11.1.3 China
      • 5.11.1.4 Japan
      • 5.11.1.5 India
      • 5.11.1.6 Australia
      • 5.11.1.7 Brazil
    • 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 MICE MODEL MARKET: REGULATORY SCENARIO
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 17 MICE MODEL MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 BARGAINING POWER OF SUPPLIERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICE MODEL MARKET
    • TABLE 18 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICE MODELS & SERVICES
    • 5.13.2 ROLE OF STAKEHOLDERS IN BUYING PROCESS
    • 5.13.3 BUYING CRITERIA FOR MICE MODEL MARKET
    • FIGURE 27 KEY BUYING CRITERIA FOR END USERS
    • TABLE 19 BUYING CRITERIA FOR MICE MODEL TYPE & SERVICE, BY END USER

6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE

  • 6.1 INTRODUCTION
    • TABLE 20 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2022-2029 (USD MILLION)
  • 6.2 MODEL TYPES
    • TABLE 21 MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 22 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 23 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 25 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 26 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 27 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 28 MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 6.2.1 INBRED MICE
      • 6.2.1.1 High utilization across research applications to propel market
    • TABLE 29 INBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 30 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 31 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 33 LATIN AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 34 MIDDLE EAST: INBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 35 GCC COUNTRIES: INBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.2 GENETICALLY ENGINEERED MICE
      • 6.2.2.1 Ability to induce mutations for CVD & cancer research to drive market
    • TABLE 36 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 37 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 38 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 40 LATIN AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 41 MIDDLE EAST: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 42 GCC COUNTRIES: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.3 HYBRID/CONGENIC MICE
      • 6.2.3.1 Growing focus on biomedical research to boost demand
    • TABLE 43 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 44 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 45 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 46 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 47 LATIN AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 48 MIDDLE EAST: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 49 GCC COUNTRIES: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.2.4 OUTBRED MICE
      • 6.2.4.1 Genetic diversity benefits to support market growth
    • TABLE 50 OUTBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 51 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 52 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 54 LATIN AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 55 MIDDLE EAST: OUTBRED MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 56 GCC COUNTRIES: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 SERVICES
    • TABLE 57 MICE MODEL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 58 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 59 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 61 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 62 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 63 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 64 MICE MODEL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 6.3.1 BREEDING SERVICES
      • 6.3.1.1 Customization of models for specific research applications to boost demand
    • TABLE 65 MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 66 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 68 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 69 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 70 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 71 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • 6.3.2 CRYOPRESERVATION SERVICES
      • 6.3.2.1 Rising focus on preservation of novel mice models to propel market
    • TABLE 72 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 73 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 74 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 76 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 77 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2022-2029 (USD MILLION)
    • TABLE 78 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.3 REDERIVATION SERVICES
      • 6.3.3.1 Stringent quality assurance standards to fuel market
    • TABLE 79 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 80 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 81 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 83 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 85 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.4 QUARANTINE SERVICES
      • 6.3.4.1 Rising demand for germ-free mice to support market growth
    • TABLE 86 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 87 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 88 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 90 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 91 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 92 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.5 OTHER SERVICES
    • TABLE 93 MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 94 NORTH AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 95 EUROPE: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 97 LATIN AMERICA: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 98 MIDDLE EAST: MICE MODEL OTHER SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 99 GCC COUNTRIES: MICE MODEL OTHER SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 MICE MODEL MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 100 MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • 7.2 CRISPR/CAS9
    • 7.2.1 ADVANTAGES SUCH AS SIMPLIFIED DESIGN AND COST EFFICIENCY TO BOOST DEMAND
    • TABLE 101 CRISPR/CAS9 MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 102 NORTH AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 103 EUROPE: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 105 LATIN AMERICA: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 106 MIDDLE EAST: CRISPR/CAS9 MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 107 GCC COUNTRIES: CRISPR/CAS9 MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 MICROINJECTION
    • 7.3.1 LOW TOXICITY AND HIGH SUCCESS RATE TO PROPEL MARKET
    • TABLE 108 MICROINJECTION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 109 NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 110 EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 112 LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 113 MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 114 GCC COUNTRIES: MICROINJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4 EMBRYONIC STEM CELL INJECTION
    • 7.4.1 RISING DEMAND FOR TARGETED MICE MODELS IN IMMUNOLOGICAL RESEARCH TO DRIVE MARKET
    • TABLE 115 EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 116 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 117 EUROPE: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 119 LATIN AMERICA: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 120 MIDDLE EAST: EMBRYONIC STEM CELL INJECTION MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 121 GCC COUNTRIES: EMBRYONIC STEM CELL INJECTION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.5 NUCLEAR TRANSFER
    • 7.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET
    • TABLE 122 NUCLEAR TRANSFER MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 123 NORTH AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 124 EUROPE: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 126 LATIN AMERICA: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 127 MIDDLE EAST: NUCLEAR TRANSFER MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 128 GCC COUNTRIES: NUCLEAR TRANSFER MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.6 OTHER TECHNOLOGIES
    • TABLE 129 OTHER TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 130 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 131 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 133 LATIN AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 134 MIDDLE EAST: OTHER TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 135 GCC COUNTRIES: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

8 MICE MODEL MARKET, BY THERAPEUTIC AREA

  • 8.1 INTRODUCTION
    • TABLE 136 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
  • 8.2 ONCOLOGY
    • 8.2.1 GROWING FOCUS ON ONCOLOGY THERAPEUTIC DEVELOPMENT TO PROPEL MARKET
    • TABLE 137 MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 138 NORTH AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 139 EUROPE: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 141 LATIN AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 142 MIDDLE EAST: MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 143 GCC COUNTRIES: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 METABOLIC DISEASES
    • 8.3.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET
    • TABLE 144 MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 145 NORTH AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 146 EUROPE: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 148 LATIN AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 149 MIDDLE EAST: MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 150 GCC COUNTRIES: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.4 IMMUNOLOGY
    • 8.4.1 INCREASING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO FUEL MARKET
    • TABLE 151 MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 152 NORTH AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 153 EUROPE: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 155 LATIN AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 156 MIDDLE EAST: MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 157 GCC COUNTRIES: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.5 NEUROLOGY
    • 8.5.1 INCREASING INVESTMENTS IN R&D FOR CNS DISEASES TO SUPPORT MARKET GROWTH
    • TABLE 158 MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 159 NORTH AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 160 EUROPE: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 162 LATIN AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 163 MIDDLE EAST: MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 164 GCC COUNTRIES: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.6 CARDIOVASCULAR DISEASES
    • 8.6.1 GROWING FOCUS ON TARGETED TREATMENTS FOR CVD TO BOOST DEMAND
    • TABLE 165 MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 166 NORTH AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 167 EUROPE: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 169 LATIN AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 170 MIDDLE EAST: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 171 GCC COUNTRIES: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.7 OTHER THERAPEUTIC AREAS
    • TABLE 172 MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 173 NORTH AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 174 EUROPE: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 175 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 176 LATIN AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 177 MIDDLE EAST: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 178 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2022-2029 (USD MILLION)

9 MICE MODEL MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 179 MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.2 DRUG DISCOVERY & DEVELOPMENT
    • 9.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET
    • TABLE 180 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 181 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 182 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 183 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 184 LATIN AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 185 MIDDLE EAST: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 186 GCC COUNTRIES: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.3 RESEARCH APPLICATIONS
    • 9.3.1 RISING FUNDING FOR CANCER RESEARCH TO BOOST DEMAND
    • TABLE 187 MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 188 NORTH AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 189 EUROPE: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 190 ASIA PACIFIC: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 191 LATIN AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 192 MIDDLE EAST: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 193 GCC COUNTRIES: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.4 PERSONALIZED MEDICINE
    • 9.4.1 GROWING PREFERENCE FOR ONCOLOGY THERAPEUTICS TO PROPEL MARKET
    • TABLE 194 MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 195 NORTH AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 196 EUROPE: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 197 ASIA PACIFIC: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 198 LATIN AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 199 MIDDLE EAST: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 200 GCC COUNTRIES: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)

10 MICE MODEL MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 201 MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 RISING EXPENDITURE ON R&D FOR DRUG DEVELOPMENT TO BOOST DEMAND
    • TABLE 202 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 203 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 204 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 206 LATIN AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 207 MIDDLE EAST: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 208 GCC COUNTRIES: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.3 ACADEMIC & RESEARCH INSTITUTES
    • 10.3.1 INCREASING FUNDING INITIATIVES FOR LIFE SCIENCES R&D TO SUPPORT MARKET GROWTH
    • TABLE 209 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 210 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 211 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 213 LATIN AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 214 MIDDLE EAST: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 215 GCC COUNTRIES: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.4 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS
    • 10.4.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO PROPEL MARKET
    • TABLE 216 MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 217 NORTH AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 218 EUROPE: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 219 ASIA PACIFIC: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 220 LATIN AMERICA: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 USD MILLION)
    • TABLE 221 MIDDLE EAST: MICE MODEL MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 222 GCC COUNTRIES: MICE MODEL MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)

11 MICE MODEL MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 223 MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 28 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
    • TABLE 224 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 225 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 226 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 227 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 228 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 229 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 230 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 231 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.2.2 US
      • 11.2.2.1 Rising production of monoclonal antibodies to fuel market for mice models
    • TABLE 232 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 233 US: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 234 US: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 235 US: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 236 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 237 US: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 238 US: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.2.3 CANADA
      • 11.2.3.1 Growth in stem cell research activities to support market growth
    • TABLE 239 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 240 CANADA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 241 CANADA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 242 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 243 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 244 CANADA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 245 CANADA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • TABLE 246 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 247 EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 248 EUROPE: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 249 EUROPE: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 250 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 251 EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 252 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 253 EUROPE: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Growing biotechnology industry to drive market
    • TABLE 254 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 255 GERMANY: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 256 GERMANY: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 257 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 258 GERMANY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 259 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 260 GERMANY: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Increasing focus on cancer research to propel market
    • TABLE 261 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 262 UK: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 263 UK: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 264 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 265 UK: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 266 UK: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 267 UK: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.4 FRANCE
      • 11.3.4.1 Increased investments in proteomics and genomics to fuel growth
    • TABLE 268 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 269 FRANCE: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 270 FRANCE: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 271 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 272 FRANCE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 273 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 274 FRANCE: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Growth in pharmaceutical and biotechnology industry to drive market
    • TABLE 275 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 276 ITALY: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 ITALY: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 278 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 279 ITALY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 280 ITALY: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 281 ITALY: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Extensive R&D pipeline to support market growth
    • TABLE 282 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 283 SPAIN: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 284 SPAIN: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 285 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 286 SPAIN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 287 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 288 SPAIN: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 289 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 290 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 291 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 292 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 293 REST OF EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 294 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 295 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 29 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT
    • TABLE 296 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 297 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 298 ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 299 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 300 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 301 ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 302 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 303 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Growing funding and investments in life sciences research to drive market
    • TABLE 304 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 305 CHINA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 306 CHINA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 307 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 308 CHINA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 309 CHINA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 310 CHINA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.3 JAPAN
      • 11.4.3.1 Increasing focus on personalized diagnostics products to drive market
    • TABLE 311 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 312 JAPAN: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 313 JAPAN: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 314 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 315 JAPAN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 316 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 317 JAPAN: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Increasing initiatives for drug discovery to boost market growth
    • TABLE 318 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 319 INDIA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 320 INDIA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 321 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 322 INDIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 323 INDIA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 324 INDIA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 High number of research institutes to favor market growth
    • TABLE 325 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 326 AUSTRALIA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 327 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 328 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 329 AUSTRALIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 330 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 331 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Rising R&D investments in drug development to fuel uptake of genetically engineered mice models
    • TABLE 332 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 333 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 334 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 335 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 336 SOUTH KOREA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 337 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 338 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 339 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 340 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 341 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 342 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 343 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 344 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 345 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 346 LATIN AMERICA: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 347 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 348 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 349 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 350 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 351 LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 352 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 353 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.5.2 BRAZIL
      • 11.5.2.1 Increasing Investments in Biopharmaceutical research to propel market growth
    • TABLE 354 BRAZIL: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 355 BRAZIL: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 356 BRAZIL: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 357 BRAZIL: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 358 BRAZIL: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 359 BRAZIL: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 360 BRAZIL: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.5.3 MEXICO
      • 11.5.3.1 Expanding healthcare ecosystem to support market growth
    • TABLE 361 MEXICO: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 362 MEXICO: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 363 MEXICO: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 364 MEXICO: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 365 MEXICO: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 366 MEXICO: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 367 MEXICO: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.5.4 REST OF LATIN AMERICA
    • TABLE 368 REST OF LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 369 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 370 REST OF LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 371 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 372 REST OF LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 373 REST OF LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 374 REST OF LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
  • 11.6 MIDDLE EAST
    • 11.6.1 MIDDLE EAST: RECESSION IMPACT
    • TABLE 375 MIDDLE EAST: MICE MODEL MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 376 MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 377 MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 378 MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 379 MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 380 MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 381 MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 382 MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.6.2 GCC COUNTRIES
    • TABLE 383 GCC COUNTRIES: MICE MODEL MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 384 GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 385 GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 386 GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 387 GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 388 GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 389 GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 390 GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
      • 11.6.2.1 SAUDI ARABIA
        • 11.6.2.1.1 Growing focus on advancement of healthcare sector to boost market growth
    • TABLE 391 SAUDI ARABIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 392 SAUDI ARABIA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 393 SAUDI ARABIA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 394 SAUDI ARABIA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 395 SAUDI ARABIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 396 SAUDI ARABIA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 397 SAUDI ARABIA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION)
      • 11.6.2.2 UNITED ARAB EMIRATES
        • 11.6.2.2.1 Increasing R&D activities and growing demand for personalized medicine to propel market
    • TABLE 398 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 399 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 400 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 401 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 402 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 403 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 404 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
      • 11.6.2.3 REST OF GCC COUNTRIES
    • TABLE 405 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 406 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 407 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 408 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 409 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 410 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 411 REST OF GCC COUNTRIES: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
    • 11.6.3 REST OF MIDDLE EAST
    • TABLE 412 REST OF MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 413 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 414 REST OF MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 415 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 416 REST OF MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 417 REST OF MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 418 REST OF MIDDLE EAST: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION
  • 11.7 AFRICA
    • 11.7.1 GROWING PRECISION MEDICINE INITIATIVES TO FUEL MARKET GROWTH
    • 11.7.2 AFRICA: RECESSION IMPACT
    • TABLE 419 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 420 AFRICA: MICE MODEL MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 421 AFRICA: MICE MODEL MARKET, BY SERVICE, 2022-2029 (USD MILLION)
    • TABLE 422 AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 423 AFRICA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2022-2029 (USD MILLION)
    • TABLE 424 AFRICA: MICE MODEL MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 425 AFRICA: MICE MODEL MARKET, BY END USER, 2022-2029 (USD MILLION

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • TABLE 426 KEY PLAYERS STRATEGIES IN MICE MODEL MARKET, 2021-2024
  • 12.3 REVENUE SHARE ANALYSIS
    • FIGURE 30 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2019-2023 (USD MILLION)
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 31 MICE MODEL MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
    • TABLE 427 MICE MODEL MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • 12.5 FINANCIAL METRICS
  • 12.6 BRAND/PRODUCT COMPARATIVE ANALYSIS
    • 12.6.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
    • FIGURE 32 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
      • 12.6.1.1 CHARLES RIVER LABORATORIES
      • 12.6.1.2 THE JACKSON LABORATORY
      • 12.6.1.3 INOTIV
      • 12.6.1.4 TACONIC BIOSCIENCES, INC.
      • 12.6.1.5 BIOCYTOGEN
    • 12.6.2 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE
    • FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SERVICE
      • 12.6.2.1 CHARLES RIVER LABORATORIES
      • 12.6.2.2 THE JACKSON LABORATORY
      • 12.6.2.3 INOTIV
      • 12.6.2.4 TACONIC BIOSCIENCES, INC.
      • 12.6.2.5 BIOCYTOGEN
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS (2023)
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • FIGURE 34 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS) 2023,
    • 12.7.5 COMPANY FOOTPRINT (KEY PLAYERS)
    • FIGURE 35 MICE MODEL MARKET: COMPANY FOOTPRINT KEY PLAYERS
    • TABLE 428 INDUSTRY FOOTPRINT (KEY PLAYERS)
    • 12.7.6 PRODUCT & SERVICE FOOTPRINT
    • TABLE 429 MICE MODEL MARKET: PRODUCT & SERVICE FOOTPRINT (KEY PLAYERS)
    • 12.7.7 REGIONAL FOOTPRINT (KEY PLAYERS)
    • TABLE 430 REGIONAL FOOTPRINT (KEY PLAYERS)
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • FIGURE 36 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 12.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
    • TABLE 431 MICE MODEL MARKET: KEY STARTUPS/SMES
    • TABLE 432 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES
    • TABLE 433 MICE MODEL MARKET: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2024
    • 12.9.2 DEALS
    • TABLE 434 MICE MODEL MARKET: DEALS, JANUARY 2021-JANUARY 2024
    • 12.9.3 EXPANSIONS
    • TABLE 435 MICE MODEL MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2024

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 CHARLES RIVER LABORATORIES
    • TABLE 436 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 37 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
    • TABLE 437 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
    • TABLE 438 CHARLES RIVER LABORATORIES: DEALS
    • TABLE 439 CHARLES RIVER LABORATORIES: EXPANSIONS
    • 13.1.2 INOTIV
    • TABLE 440 INOTIV: BUSINESS OVERVIEW
    • TABLE 441 INOTIV: PRODUCTS/SERVICES OFFERED
    • TABLE 442 INOTIV: PRODUCT LAUNCHES
    • TABLE 443 INOTIV: DEALS
    • TABLE 444 INOTIV: EXPANSIONS
    • 13.1.3 THE JACKSON LABORATORY
    • TABLE 445 THE JACKSON LABORATORY: BUSINESS OVERVIEW
    • TABLE 446 THE JACKSON LABORATORY: PRODUCTS/SERVICES OFFERED
    • TABLE 447 THE JACKSON LABORATORY: PRODUCT LAUNCHES
    • TABLE 448 THE JACKSON LABORATORY: DEALS
    • 13.1.4 SHANGHAI MODEL ORGANISMS CENTER, INC.
    • TABLE 449 SHANGHAI MODEL ORGANISMS CENTER, INC.: BUSINESS OVERVIEW
    • FIGURE 40 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 450 SHANGHAI MODEL ORGANISMS CENTER, INC.: PRODUCTS/SERVICES OFFERED
    • 13.1.5 JSR CORPORATION
    • TABLE 451 JSR CORPORATION: BUSINESS OVERVIEW
    • FIGURE 41 JSR CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 452 JSR CORPORATION: PRODUCTS/SERVICES OFFERED
    • TABLE 453 JSR CORPORATION: DEALS
    • 13.1.6 BIOCYTOGEN
    • TABLE 454 BIOCYTOGEN: BUSINESS OVERVIEW
    • FIGURE 42 BIOCYTOGEN: COMPANY SNAPSHOT (2022)
    • TABLE 455 BIOCYTOGEN: PRODUCTS/SERVICES OFFERED
    • TABLE 456 BIOCYTOGEN: PRODUCT LAUNCHES
    • TABLE 457 BIOCYTOGEN: DEALS
    • TABLE 458 BIOCYTOGEN: EXPANSIONS
    • 13.1.7 TRANS GENIC INC.
    • TABLE 459 TRANS GENIC INC.: BUSINESS OVERVIEW
    • FIGURE 43 TRANS GENIC INC.: COMPANY SNAPSHOT (2023)
    • TABLE 460 TRANS GENIC, INC.: PRODUCTS/SERVICES OFFERED
    • 13.1.8 HARBOUR BIOMED
    • TABLE 461 HARBOUR BIOMED: BUSINESS OVERVIEW
    • FIGURE 44 HARBOUR BIOMED: COMPANY SNAPSHOT (2022)
    • TABLE 462 HARBOUR BIOMED: PRODUCTS/SERVICES OFFERED
    • TABLE 463 HARBOUR BIOMED: OTHER DEVELOPMENTS
    • 13.1.9 GENOWAY
    • TABLE 464 GENOWAY: BUSINESS OVERVIEW
    • FIGURE 45 GENOWAY: COMPANY SNAPSHOT (2022)
    • TABLE 465 GENOWAY: PRODUCTS/SERVICES OFFERED
    • TABLE 466 GENOWAY: DEALS
    • 13.1.10 GEMPHARMATECH
    • TABLE 467 GEMPHARMATECH: BUSINESS OVERVIEW
    • TABLE 468 GEMPHARMATECH: PRODUCTS/SERVICES OFFERED
    • TABLE 469 GEMPHARMATECH: DEALS
    • TABLE 470 GEMPHARMATECH: EXPANSIONS
    • 13.1.11 CYAGEN
    • TABLE 471 CYAGEN: BUSINESS OVERVIEW
    • TABLE 472 CYAGEN: PRODUCTS/SERVICES OFFERED
    • 13.1.12 OZGENE PTY LTD.
    • TABLE 473 OZGENE PTY LTD.: BUSINESS OVERVIEW
    • TABLE 474 OZGENE PTY LTD.: PRODUCTS/SERVICES OFFERED
    • TABLE 475 DEALS
    • 13.1.13 TACONIC BIOSCIENCES, INC.
    • TABLE 476 TACONIC BIOSCIENCES, INC.: BUSINESS OVERVIEW
    • TABLE 477 TACONIC BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
    • TABLE 478 TACONIC BIOSCIENCES, INC.: PRODUCT LAUNCHES
    • TABLE 479 TACONIC BIOSCIENCES, INC.: DEALS
    • 13.1.14 TRANSCURE BIOSERVICES
    • TABLE 480 TRANSCURE BIOSERVICES: BUSINESS OVERVIEW
    • TABLE 481 TRANSCURE BIOSERVICES: PRODUCTS/SERVICES OFFERED
    • 13.1.15 MARSHALL BIORESOURCES
    • TABLE 482 MARSHALL BIORESOURCES: BUSINESS OVERVIEW
    • TABLE 483 MARSHALL BIORESOURCES: PRODUCTS/SERVICES OFFERED
    • 13.1.16 VIVO BIO TECH LTD.
    • TABLE 484 VIVO BIO TECH LTD.: BUSINESS OVERVIEW
    • FIGURE 46 VIVO BIO TECH LTD: COMPANY SNAPSHOT (2022)
    • TABLE 485 VIVO BIO TECH LTD.: PRODUCTS/SERVICES OFFERED
    • 13.1.17 INGENIOUS TARGETING LABORATORY
    • TABLE 486 INGENIOUS TARGETING LABORATORY: BUSINESS OVERVIEW
    • TABLE 487 INGENIOUS TARGETING LABORATORY: PRODUCTS/SERVICES OFFERED
    • 13.1.18 JANVIER LABS
    • TABLE 488 JANVIER LABS: BUSINESS OVERVIEW
    • TABLE 489 JANVIER LABS: PRODUCTS/SERVICES OFFERED
  • 13.2 OTHER PLAYERS
    • 13.2.1 APPLIED STEMCELL
    • TABLE 490 APPLIED STEMCELL: BUSINESS OVERVIEW
    • 13.2.2 CREATIVE ANIMODEL
    • TABLE 491 CREATIVE ANIMODEL: BUSINESS OVERVIEW
    • 13.2.3 JOINN LABORATORIES (CHINA) CO., LTD.
    • TABLE 492 JOINN LABORATORIES (CHINA) CO., LTD.: BUSINESS OVERVIEW
    • 13.2.4 CREATIVE BIOLABS
    • TABLE 493 CREATIVE BIOLABS: BUSINESS OVERVIEW
    • 13.2.5 CRESCENDO BIOLOGICS
    • TABLE 494 CRESCENDO BIOLOGICS: BUSINESS OVERVIEW
    • 13.2.6 ARAGEN LIFE SCIENCES
    • TABLE 495 ARAGEN LIFE SCIENCES: BUSINESS OVERVIEW
    • 13.2.7 POLYGENE
    • TABLE 496 POLYGENE: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS